Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-01-05 Diabetic nephropathy
| Finerenone |
|
Formulary
|
 NICE TA877: Finerenone for treating chronic kidney disease in type 2 diabetes |
|
Links
- Diabetes UK: Diabetes when you’re unwell
LSCMMG: GLP-1 patient contract
LSCMMG: Guidelines for the Home Monitoring of Blood Glucose Levels - LSCMMG: Lancashire and South Cumbria ICB recommended meters, strips and devices Dec 2023
- LSCMMG: Policy for Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus
- LSCMMG: Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- LSCMMG:Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- MHRA: Diabetes and driving
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG28: Type 2 diabetes in adults: management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE TA877: Finerenone for treating chronic kidney disease in type 2 diabetes